Dario Demonstrates Improved Workplace Function and Productivity Outcomes Through Digital Behavioral Health Program: Real-World Study Published in JMIR Formative Research

Rhea-AI Summary

DarioHealth (NASDAQ: DRIO) announced a peer‑reviewed JMIR Formative Research publication (April 20, 2026) reporting statistically significant improvements in workplace functioning from its digital behavioral health program.

Among users, focus and task completion improved within six weeks (n=1,254 for concentration), with larger gains by weeks 6–10; comparable gains seen for procrastination (n=1,004) and mistakes at work (n=167).

Positive

• Concentration improvements observed within 6 weeks (n=1,254)
• Procrastination improvements observed (n=1,004)
• Additional gains grew further by weeks 6–10

Negative

• Small sample for work mistakes measure: n=167

News Market Reaction – DRIO

+2.75%

1 alert

+2.75% News Effect

On the day this news was published, DRIO gained 2.75%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Findings highlight the role of continuous behavioral support in improving focus, productivity and day-to-day functioning – key priorities for employers and health plans

Statistically significant improvements in workplace functioning highlight the potential economic value of Dario's digital health solutions for payers

NEW YORK, April 20, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced the publication of new peer-reviewed research in JMIR Formative Research demonstrating meaningful improvements in workplace functioning among participants using Dario's digital behavioral health program.

The study, titled Enhancing Workplace Outcomes Through Digital Behavioral Health Programs: Retrospective Real–World Study, demonstrated statistically significant improvements in workplace functioning among users of Dario's behavioral health solutions. Among 1,254 users who reported concentration difficulties at baseline, significant improvements were observed within the first six weeks, with even greater gains by weeks 6 to 10. Comparable improvements were observed for procrastination (n=1,004) and mistakes at work (n=167). These measures – focus, task completion and accuracy – are established contributors to absenteeism and presenteeism.

For employers and health plans, the findings reinforce the connection between behavioral health and workforce productivity – an increasingly significant driver of both employee well-being and total cost of care.

"Behavioral health issues show up in missed tasks, poor focus, and stress on the job," said Omar Manejwala, MD, Chief Medical Officer of Dario. "This study shows that timely, in-the-moment support improves how people function day to day, including at work."

For employers, the stakes are significant: illness-related lost productivity – including absenteeism and reduced on-the-job performance (i.e., presenteeism) – costs U.S. employers an estimated $575 billion annually. This highlights the need for scalable solutions like Dario that help employees manage health challenges while maintaining daily functioning at work.   

"Employers are increasingly focused on solutions that can deliver measurable outcomes at scale," said Yifat Hershcovitz, PhD, VP Clinical & Scientific Affairs at Dario. "These findings further validate Dario's approach of combining behavioral science, data-driven insights and continuous engagement to help people develop sustainable habits that improve everyday functioning and health outcomes."

The publication adds to the growing body of peer-reviewed evidence supporting Dario's digital health platform, which integrates behavioral health with cardiometabolic support to address the interconnected chronic condition management needs of employer and health plan populations.

About DarioHealth Corp. (NASDAQ: DRIO)

DarioHealth Corp. (NASDAQ: DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.

Dario's user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do.

Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit http://dariohealth.com. 

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the potential economic value of the Company's digital health solutions for payers, that the costs to employers relating to illness-related lost productivity highlights the need for scalable solutions like Dario that help employees manage health challenges while maintaining daily functioning at work, and the impact of the Company's approach in the development of sustainable habits that improve everyday functioning. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™ as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate Contacts

Michael Lipari
SVP Corporate Development
irteam@dariohealth.com
+1-201-785-6310

Rob Halpern
SVP Marketing
irteam@dariohealth.com

Logo - https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/dario-demonstrates-improved-workplace-function-and-productivity-outcomes-through-digital-behavioral-health-program-real-world-study-published-in-jmir-formative-research-302745254.html

SOURCE DarioHealth Corp.

FAQ

What did Dario (DRIO) report about workplace functioning improvements on April 20, 2026?

The study reported statistically significant workplace functioning improvements among program users within six weeks. According to the company, concentration, procrastination, and mistakes at work improved, with larger gains by weeks 6–10 across stated user cohorts.

How large were the user cohorts in Dario’s April 20, 2026 study (DRIO)?

The study analyzed 1,254 users for concentration, 1,004 for procrastination, and 167 for mistakes at work. According to the company, those cohort sizes correspond to the reported real‑world retrospective analysis.

When did Dario (DRIO) participants show measurable workplace gains in the study?

Participants showed measurable gains within the first six weeks, with greater improvements in weeks 6–10. According to the company, early in‑program support produced statistically significant changes in focus and task completion.

What workplace outcomes improved in Dario’s digital behavioral health study (DRIO)?

The study found improvements in focus, task completion, and accuracy, linked to absenteeism and presenteeism. According to the company, these measures reflect reductions in concentration difficulties, procrastination, and work mistakes among users.

How might employers view Dario’s April 20, 2026 findings for DRIO?

Employers may view the findings as evidence of productivity benefits from scalable behavioral support within weeks. According to the company, improved day‑to‑day functioning could address absenteeism and presenteeism cost drivers.

Is Dario’s April 20, 2026 study peer reviewed and where was it published for DRIO?

Yes, the research is peer reviewed and published in JMIR Formative Research on April 20, 2026. According to the company, publication adds to peer‑reviewed evidence supporting its integrated digital health platform.